Rosalab
ActiveRosalab has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €75k and a net result of €181k. Equity is growing by ~14.5% per year across the filed fiscal years. Its solvency ranks better than 24% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
73
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency52▼-17
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity tight (current ratio 1.43 against 1.47 in 2024; short-term debt: 62.3% and cash: 9.7% of total assets), and 73.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
26.6%
Return on assets
64.4%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
30 d early
2024
9 d early
2023
on the day
2022
24 d early
2021
16 d early
2020
33 d early
2019
32 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€75k▼ 27.5%
2024 · €103k
2018: €27k
2019: €46k
2020: €54k
2021: €69k
2022: €93k
2023: €73k
2024: €103k
2018 → 2025
Total assets
€282k▲ 21.5%
2024 · €232k
2018: €47k
2019: €64k
2020: €67k
2021: €104k
2022: €172k
2023: €152k
2024: €232k
2018 → 2025
Net result
€181k▲ 39.4%
2024 · €130k
2018: €20k
2019: €19k
2020: €9k
2021: €23k
2022: €47k
2023: €19k
2024: €130k
2018 → 2025
Working capital
€76k▲ 25.1%
2024 · €61k
2018: €7k
2019: €21k
2020: €37k
2021: €58k
2022: €65k
2023: €40k
2024: €61k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€69k-€93k▲ 34.7%€73k▼ 21.5%€103k▲ 41.3%€75k▼ 27.5%
Operating result€32k-€65k▲ 101%€27k▼ 57.9%€177k▲ 551%€251k▲ 42.0%
Net result€23k-€47k▲ 103%€19k▼ 59.9%€130k▲ 585%€181k▲ 39.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 42% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €282k
Fixed assets
€30k▼ 28.8%
Current assets
€252k▲ 32.7%
Equity and liabilities €282k
Equity
€75k▼ 27.5%
Provisions
€31k
Debt
€176k▲ 36.3%
The debt ratio rises from 55.5% to 62.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€263k▲
2024 · €189k
Cash flow
€194k▲
2024 · €142k
Solvency
26.6%▼
2024 · 44.5%
Current ratio
1.43▼
2024 · 1.47
Quick ratio
1.43▼
2024 · 1.47
Debt / equity
2.35▲
2024 · 1.25
ROE
242.5%▲
2024 · 126.2%
ROA
64.4%▲
2024 · 56.1%
Interest coverage
663.71▲
2024 · 254.15
Debt
€176k▲
2024 · €129k
Debt ≤ 1 year
€176k▲
2024 · €129k
Income taxes
€73k▲
2024 · €46k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€232k€282k▲
Fixed assets21/28€42k€30k▼
Tangible fixed assets22/27€42k€30k▼
Furniture and vehicles24€31k€21k▼
Other tangible fixed assets26€11k€10k▼
Current assets29/58€190k€252k▲
Amounts receivable within one year40/41-€73k
Other amounts receivable41-€73k
Cash at bank and in hand54/58€140k€27k▼
Deferred charges and accrued income490/1€49k€151k▲
Equity and liabilities
Total equity and liabilities10/49€232k€282k▲
Equity10/15€103k€75k▼
Contributions10/11€19k€19k=
Reserves13€84k€56k▼
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€82k€54k▼
Profit (loss) carried forward14€151€151=
Provisions and deferred taxes16-€31k
Provisions for liabilities and charges160/5-€31k
Other liabilities and charges164/5-€31k
Amounts payable17/49€129k€176k▲
Amounts payable within one year42/48€129k€176k▲
Current portion of amounts payable after more than one year42€15k-
Trade debts44€2k€2k▲
Suppliers440/4€2k€2k▲
Taxes, remuneration and social security45€31k€49k▲
Taxes450/3€31k€49k▲
Other amounts payable47/48€81k€125k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€12k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8-€31k
Other operating charges640/8€937€480▼
Gross operating margin9900€189k€295k▲
Operating profit (loss)9901€177k€251k▲
Financial income75/76B€7€3k▲
Recurring financial income75€7€3k▲
Financial charges65/66B€742€397▼
Recurring financial charges65€742€397▼
Profit (loss) for the period before taxes9903€176k€254k▲
Income taxes67/77€46k€73k▲
Profit (loss) for the period9904€130k€181k▲
Profit (loss) for the period to be appropriated9905€130k€181k▲
Appropriation of the result
Profit (loss) to be appropriated9906€130k€182k▲
Profit (loss) brought forward from the previous period14P€151€151=
Transfer from equity791/2-€28k
Transfer to equity691/2€30k-
To other reserves6921€30k-
Profit to be distributed694/7€100k€210k▲
Return on contributions (dividend)694€100k€210k▲
The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2018net €181k ▲39.4%
Operating result €251k, net result €181k, both a record.
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €100kEq €103k ▲41.3%
7 profitable years in a row build equity to €103k.
31-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
15-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €9k ▼55.4%
Net result drops to €9k, the lowest in the series; recovery starts the following year.
29-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Joséphine Rauscent 1541300 WavreGround area
6,683 m²
Building footprint
232 m²
Parcel 25055B0565/00K000, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rosalab
since 20172.268.943.628
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25055B0565/00K000 | Wallonia | 6,683 m² | 1 · 232 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
98450000D65BBF1F9491
Similar companies · same sector, comparable size
IMAGERIE MEDICALE HELMET
BE 0465.667.997
Wavre · Eq €75k
AJ.LAB
BE 0707.955.092
Jemeppe-sur-Sambre · Eq €74k
Baerts Analytica
BE 0704.638.187
Hove · Eq €72k
MEDISCHE BEELDVORMING Dr CLAES - Dr REYGAERTS
BE 0435.557.516
Vilvoorde · Eq €78k
MEDIVIENNE
BE 1023.043.261
Sint-Pieters-Woluwe · Eq €79k
Of 698 companies in sector 86910 we hold annual accounts for 520. 303 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-10-2017
Fiscal year end31-12
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.